SCHEMBL25945305

SCHEMBL25945305

Cc1cc(C)cc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(-c3cccc4c5ccccc5n(-c5ccccc5)c34)cc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.36
RXFP1 Q9HBX9 1/20 0.34
NPY5R Q15761 1/20 0.32
KMT2A Q03164 3/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPT P10636 2/20 0.31
TP53 P04637 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
ABCB1 P08183 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
MEN1 O00255 2/20 0.31
NTSR1 P30989 1/20 0.31
NR3C1 P04150 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22586985 1.00 PTGER4 (0.36) PTGER4RXFP1NPY5RKMT2ANPC1
SCHEMBL25945303 0.95 RXFP1 (0.39) PTGER4RXFP1NPY5RKMT2ANPC1
SCHEMBL22586122 0.95 RXFP1 (0.39) PTGER4RXFP1NPY5RKMT2ANPC1
SCHEMBL22586778 0.94 RXFP1 (0.34) PTGER4RXFP1KMT2ANPC1RAB9A
SCHEMBL22586983 0.94 RXFP1 (0.34) PTGER4RXFP1KMT2ANPC1RAB9A
SCHEMBL22586777 0.93 PTGER4 (0.36) PTGER4RXFP1NPY5RKMT2AKDM4E
SCHEMBL22586356 0.93 PTGER4 (0.36) PTGER4RXFP1NPY5RKMT2AKDM4E
SCHEMBL22586924 0.92 PTGER4 (0.39) PTGER4RXFP1NPY5RKMT2AKDM4E
SCHEMBL20960805 0.92 KDM4E (0.35) PTGER4NPY5RKMT2AKDM4EATM
SCHEMBL22586927 0.92 PTGER4 (0.39) PTGER4RXFP1NPY5RKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278992-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 US disclosed
US-20230278992-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-07 US disclosed
US-11718608-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718608-B2 Organic molecules for use in optoelectronic devices OR10J3, AOX1, ALDH1A2 PTGER4 1409/4885RXFP1 4169/4885NPY5R 3460/4885
US-20230278992-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, AOX1, ALDH1A2 PTGER4 1427/4885RXFP1 4287/4885NPY5R 3591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.